abstract |
The present invention relates to Ackermancia, a mucin-degrading bacterial species found in the human intestine for the treatment of undesirable inflammatory activity not attributable to metabolic disorders and / or obesity, in particular airway inflammatory activity such as found in asthma. Regarding the use of Akkermansia muciniphila. |